[
  {
    "ts": null,
    "headline": "UNH vs. ELV: Which Managed Care Stock Has the Edge Today?",
    "summary": "Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.",
    "url": "https://finnhub.io/api/news?id=bde1df535383cd2e52168fd0e9b61f24b20be8cb7075400952b4da183dbb409b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767114900,
      "headline": "UNH vs. ELV: Which Managed Care Stock Has the Edge Today?",
      "id": 137943940,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.",
      "url": "https://finnhub.io/api/news?id=bde1df535383cd2e52168fd0e9b61f24b20be8cb7075400952b4da183dbb409b"
    }
  },
  {
    "ts": null,
    "headline": "Can Elevance (ELV) Hike Prices to Accommodate Rising Costs?",
    "summary": "Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market rally persisted in the third quarter as investors ignored tariffs, buoyed by strong corporate earnings, rising AI investment, and prospects of economic support from US fiscal policy and […]",
    "url": "https://finnhub.io/api/news?id=9d567f1f6a041d4b43b521ac963cd031de4768365a160408fac8a976c99e4558",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767096076,
      "headline": "Can Elevance (ELV) Hike Prices to Accommodate Rising Costs?",
      "id": 137940484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Artisan Partners, an investment management company, released its “Artisan Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market rally persisted in the third quarter as investors ignored tariffs, buoyed by strong corporate earnings, rising AI investment, and prospects of economic support from US fiscal policy and […]",
      "url": "https://finnhub.io/api/news?id=9d567f1f6a041d4b43b521ac963cd031de4768365a160408fac8a976c99e4558"
    }
  },
  {
    "ts": null,
    "headline": "What Do Analysts Think About Elevance Health (ELV)?",
    "summary": "Elevance Health, Inc. (NYSE:ELV) is one of the best affordable healthcare stocks to buy now. Elevance Health, Inc. (NYSE:ELV) was downgraded to Hold from Buy by Deutsche Bank analyst George Hill on December 19. The analyst also brought the price target down to $320 from $332. However, BofA lifted the price target on the stock to […]",
    "url": "https://finnhub.io/api/news?id=9c70a56472752073edd6b5ed883e94787a530a78c54430090543c99b1afc8029",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767070785,
      "headline": "What Do Analysts Think About Elevance Health (ELV)?",
      "id": 137940485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health, Inc. (NYSE:ELV) is one of the best affordable healthcare stocks to buy now. Elevance Health, Inc. (NYSE:ELV) was downgraded to Hold from Buy by Deutsche Bank analyst George Hill on December 19. The analyst also brought the price target down to $320 from $332. However, BofA lifted the price target on the stock to […]",
      "url": "https://finnhub.io/api/news?id=9c70a56472752073edd6b5ed883e94787a530a78c54430090543c99b1afc8029"
    }
  }
]